You are here
Interview with Florian Strasser at ECC 2015: New and exciting interventions for cancer cachexia
Almost all patients with advanced cancer have some level of cachexia, leading to fatigue, loss of muscle function, distress and increased toxicity of cancer treatments. As a result, cachexia reduces survival.
At the European Cancer Congress (Vienna, Austria; 25 – 29 September 2015), Dr Florian Strasser (Cantonal Hospital St. Gallen, Switzerland) said that current approaches are unsatisfactory. Drugs such as corticosteroids do not help long term, attempts to increase nutrition tend to be unsuccessful and management of the condition is often fragmented.
This may be set to change, he tells journalist Helen Saul in this video. Better understanding of the underlying mechanisms means there are several new drugs close to registration, and a new drive towards integrated management of the condition could make a real difference in the near future.